Atlas Trials

Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score

RecordFirmDate
Treatment Pause Versus Treatment Continuation in IMDC Good or Intermediate Risk With Only One Adverse Prognostic Factor in mRCC Patients With an Objective Response at 12 Months of Treatment With PD1/ PDL1 ICIs + VEGFR-Tyrosine Kinase Inhibitors (NCT05219318)University Hospital, Bordeaux2023-01-23

Track Good or Only One Adverse Prognostic Factor Intermediate Risk Per IMDC Score automatically

Every clearance here is in the API, with alerts when new ones post.